POSTER: CML-431 Second Line Treatment With Tyrosine Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) in Colombia. Report of the RENEHOC-ACHO Investigators
Clinical Lymphoma, Myeloma & Leukemia(2023)
关键词
chronic myeloid leukemia,second line,Colombia,registry
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要